Michelle Millwood, BSN
https://www.niams.nih.gov/about/directory/michelle-millwood-bsn
Michelle Millwood, RN, works on research involving Systemic Juvenile Idiopathic Arthritis (sJIA) and Juvenile Dermatomyositis (JDM) studies conducted at the NIH.
Displaying 761 - 780 of 1011 results
Kang Yu, Ph.D.
https://www.niams.nih.gov/about/directory/kang-yu-phd
Dr. Yu’s current research focuses on how super-enhancers and non-coding RNA modulate immune regulator genes and the implications in lymphocyte development, differentiation, and activation.
What Our Proteins Can Tell Us About Autoimmune Diseases
https://www.niams.nih.gov/what-our-proteins-can-tell-us-about-autoimmune-diseases
Adeline Chin, a postbaccalaureate research fellow, is searching for proteins present at abnormally high or low levels in the blood of kids with a rare autoimmune illness.
New Web Application to Study Cellular Responses to Glucocorticoids
https://www.niams.nih.gov/new-web-application-study-cellular-responses-glucocorticoids
Although the drugs have been around for more than 70 years, scientists have a poor understanding of how glucocorticoids regulate the immune system and the mechanisms by which they cause toxicity in different organs.
NIAMS Reportable Events Requirements and Guidelines for Investigators Conducting NIAMS-Funded Clinical Research Studies
A. Introduction These requirements and guidelines created by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) detail the safety reporting processes that investigators are required to follow when conducting NIAMS-supported clinical research studies. These studies include clinical trials and other types of clinical research studies e.g., observational
Scientific Peer Review
https://www.niams.nih.gov/grants-funding/scientific-peer-review
An overview of the Scientific Review Branch (SRB). SRB is responsible for the initial scientific and technical merit review of grant applications submitted in response to NIAMS requests for applications, program announcements with special receipt, referral, and/or review considerations, career development (K) awards, R13 conference grants, clinical trials, and other special initiatives.
Engineered cartilage produces anti-inflammatory drug
https://www.niams.nih.gov/engineered-cartilage-produces-anti-inflammatory-drug
NIAMS Forum for Clinical Mentored K Awardees - December 2020
https://www.niams.nih.gov/newsroom/roundtable/niams-forum-clinical-mentored-k-awardees-december-2020
NIAMS held its first K Forum in 2012. Based on the positive feedback received from participants, NIAMS convened subsequent meetings annually. T
Research: MicroRNA-221 and -222 modulate intestinal inflammatory Th17 cell response as negative feedback regulators downstream of interleukin-23
https://www.niams.nih.gov/newsroom/featured/new-research-published-journal-immunity
In a recent study in the journal Immunity, NIAMS investigators provide new insight into mechanisms of disease by the adaptive immune system.
Dr. Kaplan Receives GPP Outstanding Mentor Award
https://www.niams.nih.gov/labs/dr-kaplan-receives-gpp-outstanding-mentor-award
We are delighted to announce that Mariana Kaplan, M.D., Deputy Scientific Director of NIAMS and Chief of the Systemic Autoimmunity Branch, has received a 2021 Graduate Partnership Program Outstanding Mentor Award. This award recognizes outstanding mentors for their leadership and dedication to their graduate students.
Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Initiative Research Opportunity Announcements (ROAs)
This notice is to make you aware that NIH has published two Research Opportunity Announcements (ROAs) as part of its new Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) initiative. NIH is soliciting proposals for research that will improve understanding of and contribute to strategies to prevent and treat post-acute manifestations of
NIAMS Alum Appointed Chairman of Rheumatology and Clinical Immunology at Kyoto University
The NIAMS congratulates Professor Akio Morinobu on his appointment as Chairman of Rheumatology and Clinical Immunology at Kyoto University, Japan.
NIAMS’ John O’Shea Awarded 2021 Harrington Prize for Innovation in Medicine
For his groundbreaking work in immunology, John J. O’Shea, M.D., will receive the eighth annual Harrington Prize for Innovation in Medicine.
How to Manage Low Back Pain Before it Gets Worse
https://www.niams.nih.gov/how-manage-low-back-pain-it-gets-worse
Skin 101: Identifying common conditions
https://www.niams.nih.gov/skin-101-identifying-common-conditions
Advantage, Wozniacki: Tennis star on taking charge of life with RA
https://www.niams.nih.gov/advantage-wozniacki-tennis-star-taking-charge-life-ra
Dr. Sarfaraz Hasni Receives 2021 Coleman Research Innovation Award
We are delighted to announce that Sarfaraz Hasni, M.D., Director of the NIAMS Lupus Clinical Trials Unit, has received the 2021 William G. Coleman Jr., Ph.D., Minority Health and Health Disparities Research Innovation Award.